{"transactions":[{"id":737837,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T20:30:20.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":6.21,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-271165","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000119312526271165/ownership.xml","form_type":"4"}},{"id":737836,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T20:30:20.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":38500,"source":{"system":"sec-edgar","filing":"0001193125-26-271165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000119312526271165/ownership.xml","form_type":"4"}},{"id":1106353,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T20:10:21.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":6.18,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000950170-25-087889","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000095017025087889/ownership.xml","form_type":"4"}},{"id":1106352,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-18T20:10:21.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":23500,"source":{"system":"sec-edgar","filing":"0000950170-25-087889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000095017025087889/ownership.xml","form_type":"4"}},{"id":1470721,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T20:09:00.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":14500,"derivative":{"exercise_price":6.93,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0000950170-24-076715","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000095017024076715/ownership.xml","form_type":"4"}},{"id":1470720,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:09:00.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0000950170-24-076715","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000095017024076715/ownership.xml","form_type":"4"}},{"id":1656806,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T23:26:40.000Z","date":"2024-02-03","kind":"grant","planned":false,"acquired":true,"shares":549400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":549400,"derivative":{"exercise_price":5.18,"expiration_date":"2034-02-02","underlying":"Common Stock","underlying_shares":549400},"source":{"system":"sec-edgar","filing":"0001104659-24-011195","document":"tm245295-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465924011195/tm245295-1_4seq1.xml","form_type":"4"}},{"id":1656805,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-06T23:26:40.000Z","date":"2024-02-05","kind":"sale","planned":false,"acquired":true,"shares":19642,"price":4.86,"value":95460.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock of the Corporation sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.72 to $4.94, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":588701,"source":{"system":"sec-edgar","filing":"0001104659-24-011195","document":"tm245295-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465924011195/tm245295-1_4seq1.xml","form_type":"4"}},{"id":1656804,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-06T23:26:40.000Z","date":"2024-02-03","kind":"grant","planned":false,"acquired":true,"shares":180400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 3, 2024, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":608343,"source":{"system":"sec-edgar","filing":"0001104659-24-011195","document":"tm245295-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465924011195/tm245295-1_4seq1.xml","form_type":"4"}},{"id":1661789,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-03T00:00:22.000Z","date":"2024-01-31","kind":"sale","planned":false,"acquired":false,"shares":18338,"price":4.95,"value":90773.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 30, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person's sale of shares of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 6,500 shares, with the reporting person's indirect purchase of 6,500 shares of common stock at a price of $3.81 per share effected August 30, 2023. The reporting person has paid to the Corporation an aggregate amount of $7,401.55, representing the amount of the profit realized in connection with the short-swing transaction."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 30, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person's sale of shares of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 6,500 shares, with the reporting person's indirect purchase of 6,500 shares of common stock at a price of $3.81 per share effected August 30, 2023. The reporting person has paid to the Corporation an aggregate amount of $7,401.55, representing the amount of the profit realized in connection with the short-swing transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.82 to $5.06, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) this Form 4."}],"balance_after":427943,"source":{"system":"sec-edgar","filing":"0001104659-24-010231","document":"tm245049-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465924010231/tm245049-1_4seq1.xml","form_type":"4"}},{"id":1789276,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-05T12:27:53.000Z","date":"2023-08-30","kind":"purchase","planned":false,"acquired":true,"shares":6500,"price":3.81,"value":24765.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001104659-23-098019","document":"tm2325262d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465923098019/tm2325262d1_4seq1.xml","form_type":"4"}},{"id":1860600,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T20:57:56.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 7, 2024 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":16000,"derivative":{"exercise_price":12.83,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000899243-23-015209","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000089924323015209/doc4.xml","form_type":"4"}},{"id":2026563,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-09T00:29:42.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":19669,"price":4.24,"value":83396.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2023. The reporting person structured the durable automatic sales instructions to constitute a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2023. The reporting person structured the durable automatic sales instructions to constitute a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.32, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":446281,"source":{"system":"sec-edgar","filing":"0001104659-23-014678","document":"tm235900-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465923014678/tm235900-1_4seq1.xml","form_type":"4"}},{"id":2038577,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T00:32:25.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":536900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":536900,"derivative":{"exercise_price":3.88,"expiration_date":"2033-01-29","underlying":"Common Stock","underlying_shares":536900},"source":{"system":"sec-edgar","filing":"0001104659-23-009410","document":"tm235116-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465923009410/tm235116-1_4seq1.xml","form_type":"4"}},{"id":2038576,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-02T00:32:25.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":176300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 30, 2023, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 363,050 shares of common stock of the Company underlying unvested RSUs."}],"balance_after":465950,"source":{"system":"sec-edgar","filing":"0001104659-23-009410","document":"tm235116-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465923009410/tm235116-1_4seq1.xml","form_type":"4"}},{"id":2227982,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T21:06:50.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 15, 2023 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":16000,"derivative":{"exercise_price":13.72,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000899243-22-023125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000089924322023125/doc4.xml","form_type":"4"}},{"id":2410157,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-08T00:28:28.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":560200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":560200,"derivative":{"exercise_price":5.27,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":560200},"source":{"system":"sec-edgar","filing":"0001104659-22-012918","document":"tm225652-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465922012918/tm225652-1_4seq1.xml","form_type":"4"}},{"id":2410156,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-08T00:28:28.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":186750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 3, 2022, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 186,750 shares of common stock of the Company underlying unvested RSUs."}],"balance_after":289650,"source":{"system":"sec-edgar","filing":"0001104659-22-012918","document":"tm225652-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465922012918/tm225652-1_4seq1.xml","form_type":"4"}},{"id":2531899,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-29T23:27:33.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as follows: These shares will vest in full on October 28, 2022."}],"balance_after":16000,"derivative":{"exercise_price":14,"expiration_date":"2031-10-27","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000899243-21-042087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000089924321042087/doc4.xml","form_type":"4"}},{"id":2592382,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-24T12:49:25.000Z","date":"2021-08-20","kind":"purchase","acquired":true,"shares":5000,"price":9.89,"value":49450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.88 to $9.89, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":102900,"source":{"system":"sec-edgar","filing":"0001104659-21-108777","document":"tm2125747-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465921108777/tm2125747-1_4seq1.xml","form_type":"4"}},{"id":2846355,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:30:44.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":455000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":455000,"derivative":{"exercise_price":18.31,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":455000},"source":{"system":"sec-edgar","filing":"0001104659-21-025785","document":"tm217246-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465921025785/tm217246-3_4seq1.xml","form_type":"4"}},{"id":3294985,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-03T23:28:37.000Z","date":"2020-01-30","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":360000,"derivative":{"exercise_price":4.39,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001104659-20-009945","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465920009945/a4.xml","form_type":"4"}},{"id":3495815,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-06-10T20:53:30.000Z","date":"2019-06-06","kind":"purchase","acquired":true,"shares":40000,"price":2.81,"value":112400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.79 to $2.82, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":97900,"source":{"system":"sec-edgar","filing":"0001104659-19-034632","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465919034632/a4.xml","form_type":"4"}},{"id":3704304,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T23:26:54.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":400000,"derivative":{"exercise_price":4.1,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001104659-19-000889","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465919000889/a4.xml","form_type":"4"}},{"id":3837268,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-08-21T20:30:59.000Z","date":"2018-08-20","kind":"purchase","acquired":true,"shares":20000,"price":5.95,"value":119000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.93 to $5.97, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":57900,"source":{"system":"sec-edgar","filing":"0001104659-18-053039","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465918053039/a4.xml","form_type":"4"}},{"id":3846284,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-13T20:43:04.000Z","date":"2018-08-10","kind":"purchase","acquired":true,"shares":16900,"price":6.23,"value":105287.0,"ownership":{"direct":true},"balance_after":37900,"source":{"system":"sec-edgar","filing":"0001104659-18-051518","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465918051518/a4.xml","form_type":"4"}},{"id":4079412,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-02T21:34:01.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":360000,"derivative":{"exercise_price":5.47,"expiration_date":"2028-01-30","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001104659-18-006258","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465918006258/a4.xml","form_type":"4"}},{"id":4133485,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and C.E.O."}}],"security":"Common Stock","published_at":"2017-12-13T22:15:19.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":21000,"price":4.29,"value":90090.0,"ownership":{"direct":true},"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001104659-17-073177","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465917073177/a4.xml","form_type":"4"}},{"id":4274666,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-22T20:44:40.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":590000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and 2.0833% of the shares vesting monthly thereafter."}],"balance_after":590000,"derivative":{"exercise_price":10.94,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":590000},"source":{"system":"sec-edgar","filing":"0001104659-17-040955","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000110465917040955/a4.xml","form_type":"4"}}]}